A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/103.1, 167/1
A61K 38/21 (2006.01) A61K 38/19 (2006.01)
Patent
CA 1335175
Disclosed are improved methods for the treatment of lung membrane diseases such as respiratory distress syndrome (RDS) or idiopathic RDS, employing compositions including therapeutically effective amounts of gamma interferon and/or tumor necrosis factor (TNF), each alone or in combination with corticosteroids, preferably employing recombinant human gamma interferon and/or TNF. Individuals, including adults or children, are administered amounts of these agents that are generally effective to induce the lungs of affected individuals to produce one or more surfactant components, including both phospholipid and surfactant protein substituents.
573984
Dennison Associates
Genentech Inc.
LandOfFree
Methods and compositions for the treatment of lung conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for the treatment of lung conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for the treatment of lung conditions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1193185